How does a start-up company like Encore Path obtain its funding?
As a clinically-proven medical device with many attributes, Tailwind has attracted the interest of public and private investors. In early 2008, Encore Path received public funding from the National Institutes of Health to further develop stroke rehabilitation technologies. In addition, the Company has also received funding from the Maryland Technology Development Corporation, the Maryland Department of Business and Economic Development, the University of Maryland, and has won several business plan competitions around the country. Private investors, including specialists in physical therapy, have also invested in the company.
